earnings
confidence high
sentiment positive
materiality 0.70
Danaher Q3 2025: EPS $1.27 GAAP, $1.89 adjusted; revenue up 4.5% to $6.1B
DANAHER CORP /DE/
2025-Q3 EPS reported
$3.37
revenue$17,730,000,000
- Net earnings $908M ($1.27 diluted EPS); non-GAAP adjusted diluted EPS $1.89.
- Revenue $6.1B, up 4.5% YoY; non-GAAP core revenue up 3.0% YoY.
- Operating cash flow $1.7B; non-GAAP free cash flow $1.4B.
- Full-year 2025 adjusted diluted EPS guidance maintained at $7.70-$7.80; core revenue expected low-single-digit growth.
- Cepheid respiratory revenue better-than-anticipated; bioprocessing momentum cited as key driver.